Search Results 641-650 of 17936 for Assay

1. Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

   Based on these discoveries, our team is working to develop a clinically viable assay for p95HER2 expression in breast cancer. In addition, we're working ...

2. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Serum free light chain (FLC) assay: involved FLC assay ≥ 10 mg/dL and an abnormal serum FLC ratio (< 0.26 or > 1.65). Patients with RR-NHL must be relapsed ...

3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   A negative QuantiFERON® TB-Gold In-Tube test (or centrally reported equivalent assay) at screening; AND; A chest radiograph (views as per local guidelines) ...

4. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

   A positive serum free lite assay is acceptable. ECOG performance status of 0 - 2. Meet all institutional requirements for autologous stem cell ...

5. Precision medicine for breast cancer - Mayo Clinic

   Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.

6. 10x Genomics Visium HD, CytAssist - Spatial Multiomics Core - Mayo Clinic Research Core Facilities

   The assay uses probe-based gene expression chemistry and requires the use of the Visium CytAssist to facilitate the transfer of transcriptomic probes from ...

7. Clinical trials - Oncology (Medical)

   cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

8. Examining the role of growth differentiation factors, senescence-related proteins and physical activity intervention in clinical outcomes

   LeBrasseur notes that the team has developed a novel assay to accurately quantify GDFs in small volumes of human plasma. Specific aims. According to Dr ...

9. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   The assay must have been performed locally by a Clinical Laboratory Improvement Act (CLIA) (or equivalent) certified laboratory. The type of assay will be ...

10. Xiaogang Li, Ph.D. - Mayo Clinic Faculty Profiles

    ... assay, ChIP and ChIP-sequencing assay, and single-cell sequencing analysis. This work should increase understanding of PKD pathophysiology and identify ...